Suzanne L. Topalian, MD of Johns Hopkins Kimmel Comprehensive Cancer Center gives an overview of presentations at the AACR 2017…
Browsing: Acute Lymphoblastic Leukemia
Suzanne L. Topalian, MD of Johns Hopkins Kimmel Comprehensive Cancer Center gives an overview of the AACR presentations, which focused…
Kazuaki Takabe, MD, PhD of Roswell Park Cancer Institute discusses the use of liquid biopsies of microRNAs as a follow-up…
Kazuaki Takabe, MD, PhD of Roswell Park Cancer Institute describes the lack of immunotherapy in treatment for breast cancer, stating…
Kazuaki Takabe, MD, PhD of Roswell Park Cancer Institute gives an overview of his abstract, Novel microRNA signature score to…
Kazuaki Takabe, MD, PhD of Roswell Park Cancer Institute discusses whether or not early detection of metastasis can help overall…
Brian Rini, MD, Bernard Escudier, MD, James Larkin, MD and Cora N Sternberg, MD outline the challenges and Navigating the…
Jonathan D. Powell, MD, PhD of Johns Hopkins University, School of Medicine explains what types of tumors would the new…
Jonathan D. Powell, MD, PhD of Johns Hopkins University, School of Medicine discusses the treatment trends for 2017 which include…
Jonathan D. Powell, MD, PhD of Johns Hopkins University, School of Medicine explains the importance of targeting metabolism for cancer…
Jonathan D. Powell, MD, PhD of Johns Hopkins University, School of Medicine discusses his presentation topic, Immunometabolism in Immunotherapy, which…
Mateusz Opyrchal, MD, PhD of Roswell Park Cancer Institute discusses the treatment trends for 2017 in cancer, which includes immunotherapy.…
Mateusz Opyrchal, MD, PhD of Roswell Park Cancer Institute explains whether or not AURKA will play a role in melanoma…
Mateusz Opyrchal, MD, PhD of Roswell Park Cancer Institute discusses how the data from the AURKA study shows a possibility…
Mateusz Opyrchal, MD, PhD of Roswell Park Cancer Institute gives an overview of his abstract, Inhibition of AURKA induces Raf1-independent…
Richard Koya, MD, PhD of Roswell Park Cancer Institute explains the treatment trends for 2017, which include immunotherapy, t-cell therapy,…
Richard Koya, MD, PhD of Roswell Park Cancer Institute explains the significance of how tumors evolve from one type of…
Richard Koya, MD, PhD of Roswell Park Cancer Institute discusses the process of manufacturing products for research at Roswell Park.…
Richard Koya, MD, PhD of Roswell Park Cancer Institute discusses how the persistency of t-cell receptors against cancer can be…
Richard Koya, MD, PhD of Roswell Park Cancer Institute gives an overview of his presentation, Sustained efficacy of immunotherapy for…
Richard Koya, MD, PhD of Roswell Park Cancer Institute explains how the new data on T-Cell receptors impacts next generation…
In this presentation from the 21st Annual Perspectives in Thoracic Oncology, Dr. Evan W. Alley discusses the role of angioinhibition…
In this presentation from the 21st Annual Perspectives in Thoracic Oncology, Dr. Charles B. Simone, II elucidates use of IMRT,…
In this presentation from the 21st Annual Perspectives in Thoracic Oncology, Dr. Charu Aggarwal discusses attempts to integrate novel targeted…
In this presentation from the 21st Annual Perspectives in Thoracic Oncology, Dr. Tracey L. Evans discusses whether there are any…
In this presentation from the 21st Annual Perspectives in Thoracic Oncology, Dr. Charles B. Simone, II argues in favor of…
In this presentation from the 21st Annual Perspectives in Thoracic Oncology, Dr. Harvey I. Pass argues in favor of surgery…
In this presentation from the 21st Annual Perspectives in Thoracic Oncology, Dr. Anil Vachani discusses when and how to intervene…
In this presentation from the 21st Annual Perspectives in Thoracic Oncology, Dr. Anil Vachani discusses the impact of the National…
In this presentation from the 21st Annual Perspectives in Thoracic Oncology, Dr. Shakun M. Malik discusses novel protocol designs in…
Jürgen Gschwend, MD, PhD of the Technical University of Munich School of Medicine and Viktor Grünwald MD, PhD of the…
Howard L. Kaufman, MD, FACS of Rutgers Cancer Institute of New Jersey discusses the treatment trends for 2017. He explains…
Howard L. Kaufman, MD, FACS of Rutgers Cancer Institute of New Jersey gives an overview of presentations at AACR 2017…
Howard L. Kaufman, MD, FACS of Rutgers Cancer Institute of New Jersey gives an overview of his current research, a…
Howard L. Kaufman, MD, FACS of Rutgers Cancer Institute of New Jersey explains whether or not there is a biomarker…
Howard L. Kaufman, MD, FACS of Rutgers Cancer Institute of New Jersey explains the impact of data on future research,…
Howard L. Kaufman, MD, FACS of Rutgers Cancer Institute of New Jersey discusses the use of avelumab, a new agent…
Jean-Pierre J. Issa, MD of Fox Chase Cancer Center Fels Institute for Cancer Research & Molecular Biology at Temple University discusses…
Jean-Pierre J. Issa, MD of Fox Chase Cancer Center Fels Institute for Cancer Research & Molecular Biology at Temple University explains…
Jean-Pierre J. Issa, MD of Fox Chase Cancer Center Fels Institute for Cancer Research & Molecular Biology at Temple University gives…
Jean-Pierre J. Issa, MD of Fox Chase Cancer Center Fels Institute for Cancer Research & Molecular Biology at Temple University gives…
Jean-Pierre J. Issa, MD of Fox Chase Cancer Center Fels Institute for Cancer Research & Molecular Biology at Temple University discusses…
Jean-Pierre J. Issa, MD of Fox Chase Cancer Center Fels Institute for Cancer Research & Molecular Biology at Temple University discusses…
Kishore Guda, DMV, PhD of Case Western Reserve University gives an overview of his presentation, Mutational Landscapes of African American…
Kishore Guda, DMV, PhD of Case Western Reserve University explains how mutations in genes could potentially be used as biomarkers.…
Kishore Guda, DMV, PhD of Case Western Reserve University stresses the importance of finding data from diverse ethnic populations. He…
Kishore Guda, DMV, PhD of Case Western Reserve University discusses the existing social stigmas for ethnic populations in cancer research.…
David Goodrich, PhD of Roswell Park Cancer Institute, Department of Pharmacology and Therapeutics explains the use of combination therapy to…
David Goodrich, PhD of Roswell Park Cancer Institute, Department of Pharmacology and Therapeutics discusses his hopes for new clinical trials…
David Goodrich, PhD of Roswell Park Cancer Institute, Department of Pharmacology and Therapeutics discusses his hopes for new targets to…